Gel electrophoresis mobility shift assay (EMSA) is a long-established biochemical technique for the qualitative assessment of nucleotide--protein complexes \[[@B1]\]. This method combines the principles of protein and oligonucleotide electrophoresis to determine biochemical relationships between these species. Ribonucleotide-based EMSAs (REMSAs) are a modified version of this technique to evaluate ribonucleotide--protein complexes. Most often, REMSAs are employed for the validation of RNA-binding proteins (RBPs) to their regulated transcripts.

Although the current methodology of this application is informative, its output is largely qualitative, with a variety of resolution and sensitivity issues. Earlier renditions of this method used radioisotopes such as ^32^P for tagging oligonucleotides (oligos). Radioactive labeling is a labor-intensive process, resulting in issues with efficiency, cost and safety \[[@B2],[@B5]\]. To address these challenges, one major improvement has replaced radioisotope tagging with biotin conjugation. This labeling technique relies on its affinity against avidin-based proteins for specific isolation of complexes \[[@B8]\].

Biotin end-labeled probes are easier and safer to use than radioisotope-based applications; however, this method still requires additional time-consuming steps after initial electrophoresis. Notably, after separating transcripts on a nondenaturing gel, contents must be cross-linked and transferred to a matrix membrane. Anti-streptavidin--HRP conjugate and substrate are then needed to develop the blots and visualize gel shifts. These additional steps not only add to the overall process time (i.e., 4--6 h), but also add extra materials, cost and optimization time.

To further address the limitations of prior assays, we end-labeled RNA transcripts with near-infrared (NIR) fluorescent dyes \[[@B4],[@B11]\]. RNA oligos were ordered and synthesized from integrated DNA technologies (IDT, IA, USA) ([Figure 1](#F1){ref-type="fig"}A). The specific NIR dyes and sequences of the transcripts that were used in the following experiments are described in [Table 1](#T1){ref-type="table"}. After electrophoresis, gels were immediately imaged on an NIR scanner (LI-COR Odyssey scanner, NE, USA). The sensitivity of these conjugated dyes allows for quantitative analysis of bound and unbound probes ([Figure 1](#F1){ref-type="fig"}B). Although not demonstrated here, the minimum detectable concentrations of probes may be optimized to save materials and to visualize protein--oligonucleotide association. The cost of synthesizing each NIR-conjugated probe is roughly US\$100 more than a biotin-labeled probe; however, considering that the fluorescent signal can be quantitated directly, gel transfer to a membrane is not necessary to visualize samples, and, therefore, provides a more time-efficient and economical option.

![Near-infrared-labeled oligonucleotides provide sensitive and quantitative detection of protein--RNA complexes.\
**(A)** RNA oligonucleotides synthesized with near-infrared (NIR) labels by Integrated DNA Technologies (IA, USA). **(B)** (1:1) Titration of \[1 μM\] IR-labeled probe in 1× LB running buffer. **(C & D)** A fixed concentration of NIR-labeled probe \[62.5 nM\] run with titrated nondenaturing, crude-cell lysate versus recombinant HuR (Origene, MD, USA). Reactions run at 250 V for 10 min at room temperature. Gels were imaged directly on an infrared scanner (Licor, NE, USA) at a wavelength corresponding to the tagged NIR dye (690 nm). All gels comprised of 1× LB (MD, USA), 5% acrylamide/bis, 10% APS, and TEMED (BioRad, CA, USA). Data in **(C & D)** are representative of at least two separate experiments.\
APS: Ammonium persulfate; LB: Lithium boric acid; NIR: Near-infrared; TEMED: Tetramethylethylenediamine.](btn-68-101-g1){#F1}

###### Near-infrared labeled RNA oligonucleotides.

  Name                  Sequence                                                         Use
  --------------------- ---------------------------------------------------------------- ------------------
  COX2-3′UTR (49 bps)   5′-/5IRD700/UCUAUUAAUUUAAUUAUUUAAUAAUAUUUAUAUUAAACUCCUUAU-3′     Positive control
  WEE1-EXON2 (49 bps)   5′/5IRD700/GAAACAGACCUGCUAAGGUGUGUGAAGAGGCUGGAUGGAUGCAGAACG-3′   Negative control
  WEE1-10T (49 bps)     5′/5IRD700/UGUGUGUCCAUCUUAUAUUUCUUUUUUUUUUAAUUGUGAAUUAGACUU-3′   Experimental

bp: Base pair; NIR: Near-infrared; 3′UTR: 3′-Untranslated region.

To demonstrate the function of these probes within biologic contexts, we used a defined RBP--ribonucleic acid relationship between the RBP, HuR/ELAVL1 and one of its mRNA targets, COX-2 \[[@B12],[@B13]\]. NIR probe concentrations were optimized through titration experiments ([Figure 1](#F1){ref-type="fig"}B). For these experiments, total protein was either extracted from crude cell lysate under nondenaturing conditions, or purchased as recombinant protein (Origene, MD, USA). To determine optimal protein concentration (i.e., whole-cell extracts or recombinant proteins), a fixed probe concentration was incubated with titrating amounts of lysate to visualize a gel shift (i.e., clear interpretable shifts in the bound probe as compared with the unbound probe) ([Figure 1](#F1){ref-type="fig"}C & D). Nontargeted recombinant tRNA (Thermo Fisher Scientific, NE, USA) was included in to reduce nonspecific binding between probes and HuR ([Figure 1](#F1){ref-type="fig"}C & D). Complexes were incubated at room temperature for 30 min in the dark before being loaded in a 5% weight by volume (w/v) acrylamide gel. [Table 2](#T2){ref-type="table"} outlines specific reaction components and concentrations are outlined in. [Table 3](#T3){ref-type="table"} describes assay buffers in depth.

###### Lithium-based, near infrared RNA electrophoretic mobility shift assay reagents.

  Nondenaturing lysis buffer[^†^](#T2TFN1){ref-type="table-fn"}   Final concentration
  --------------------------------------------------------------- -------------------------------------
  Tris--HCl (pH 7.5)                                              75 mM
  Sodium chloride (NaCl)                                          150 mM
  Magnesium chloride (MgCl~2~)                                    1 mM
  Nonidet P-40 (or IGEPAL-CA630)                                  1% (v/v)
  Phenylmethane sulfonyl fluoride (PMSF)                          1 mM
  Protease inhibitor cocktail (PI)                                1 mM
  Sodium orthovanadate (Na~3~VO~4~)                               1 mM
  **5× binding buffer**                                           **Final concentration**
  HEPES (pH 7.4)                                                  75 mM
  Potassium chloride (KCl)                                        50 mM
  Glycerol                                                        50% (v/v)
  Dithiothreitol (DTT)                                            1 mM
  Magnesium chloride (MgCl~2~)                                    25 mM
  **Binding reaction components**                                 **Final concentration**
  tRNA                                                            5 μg
  Fluorophore-tagged RNA                                          [^‡^](#T2TFN2){ref-type="table-fn"}
  Protein lysate or recombinant protein                           [^‡^](#T2TFN2){ref-type="table-fn"}
  5× binding buffer                                               1×
  5× loading dye                                                  1×
  Deionized water                                                 \-

Only for protein extraction with whole-cell lysates.

Optimize based on the assay requirement.

###### Tris-boric acid-disodium EDTA versus lithium boric acid method components.

  1× TBE gel components                            Final concentration
  ------------------------------------------------ -------------------------
  Sterile DI H~2~O                                 \-
  30% acrylamide/bis (29:1 acrylamide:bis ratio)   5% (w/v)
  10× TBE                                          1×
  Ammonium persulfate (APS)                        10% (v/v)
  TEMED (N,N,N′,N′-Tetramethylethylenediamine)     1% (v/v)
  Sterile DI H~2~O                                 \-
  **1× TBE running buffer**                        **Final concentration**
  10× Tris-boric acid-disodium EDTA                1×
  **1× LB gel components**                         **Final concentration**
  Sterile DI H~2~O                                 \-
  30% acrylamide/bis (29:1 acrylamide:bis ratio)   5% (w/v)
  20× LB medium                                    1×
  APS                                              10% (v/v)
  TEMED (N,N,N′,N′-Tetramethylethylenediamine)     1% (v/v)
  **1× LB running buffer**                         **Final concentration**
  20× LB medium                                    1×

APS: Ammonium persulfate; LB: Lithium boric acid; TBE: Tris-boric acid-disodium EDTA; v/v: Volume by volume; w/v: Weight by volume.

The second limitation of former REMSA methods is the use of Tris-based (Tris-HCL/Boric Acid/EDTA, TBE) conductive media, most likely adapted from early electrophoretic methods \[[@B10]\]. Because of its poor conductivity and high heat of reaction owing to Ohm\'s law, TBE causes poor oligonucleotide resolution \[[@B9],[@B10]\]. For this reason, TBE gels must be run for long stretches of time (\>90 min) at low voltages to maintain gel--complex integrity. To resolve resolution issues and improve the reaction time, we exchanged TBE (Fischer Scientific, NH, USA) for a more effective low-molarity conductive media, lithium boric acid (LB) (Faster Better Media, LLC, MD, USA) \[[@B8]\]. It has long been demonstrated that agarose-based electrophoresis LB media is able to rapidly separate DNA and RNA species at high voltages, without compromising resolution or sensitivity \[[@B8]\]. Moreover, the cost of 1 liter of 10× TBE is the same as commercial liter bottles of 10× LB buffer at roughly US\$50 unit purchase. To evaluate the improved buffering capacity of the LB method, 5% w/v gels were cast and ran with 1× TBE or LB medium, as indicated ([Table 3](#T3){ref-type="table"}). The temperature, current and integrity of the gel were evaluated at fixed run times and at high voltage (300 V) ([Figure 2](#F2){ref-type="fig"}). Under each run time, LB was able to separate oligos with enhanced resolution, demonstrating a more pronounced gel shift, as indicated by clear separation of 'probe only' and 'probe plus HuR protein' lanes ([Figure 2](#F2){ref-type="fig"}). As expected, the final temperatures of the TBE gel were elevated over the LB-based method, despite similar volumes of media used and equal thickness of the gels prepared \[[@B9],[@B10]\]. When we separated the glass gel sandwich, we noted that the physical integrity of the TBE gel was significantly impaired compared with the solid matrix of the LB gel. In addition, we noted that the TBE gels showed an increased temperature of 5°C over the running of the assay, whereas LB gels increased roughly 3°C or lower. In terms of conductance, LB gels ran at a constant 30 milliamps, whereas the TBE gels rose from 40 to 80 milliamps. This expected relationship between conductance and temperature was previously described in agarose gel electrophoresis systems \[[@B10],[@B12]\]. Based on these results, we demonstrate that higher voltages over a shorter period of time are possible without deleterious temperature increases that may impact gel integrity and assay resolution ([Figure 2](#F2){ref-type="fig"}). Here, we refer to this improved protocol as **l**ithium-based, near-**i**nfrared REMSA (LI-REMSA).

![Improved resolution and assay time with lithium boric acid conductive media versus Tris-boric acid-disodium EDTA method.\
**(A)** 1× TBE gel and **(B)** 1× LB gel ran fast (300 V) for 7 min, as indicated. **(C & D)** Gels may be run longer without compromising resolution, in which the same gels were returned to the reservoirs, and run for an additional 5 min (total assay time: 12 min). After run time, gels were removed from the reservoirs and were imaged using infrared scanner (LICOR, NE, USA) at a wavelength corresponding to the tagged NIR dye (690 nm). Data shown in the figure are representative of at least three separate experiments. Gel temperatures were monitored by placing standard thermometer directly in reservoir before and after completion of the run.\
LB: Lithium boric acid; TBE: Tris-boric acid-disodium EDTA; T~0~: Initial temperature; T~F~: Final temperature.](btn-68-101-g2){#F2}

REMSAs are classically used for validation of RBP target sequences within an mRNA transcript of interest *in vitro*. Here, we validated a previously predicted binding site of a HuR-regulated transcript, WEE1 (the G2/M mitotic checkpoint inhibitor) mRNA, using LI-REMSA ([Figure 3](#F3){ref-type="fig"}) \[[@B14]\]. Each probe was incubated with either recombinant HuR or FOXP3, a negative control transcription factor (i.e., that should not bind to WEE1 mRNA). A sequence within the second exon of the WEE1 mRNA was used as a negative control. The WEE1 Exon2 mRNA probe, which lacks adenylate-uridylate-rich elements required for HuR recognition, demonstrated unresolved resolution with a large percentage of unbound free probe, indicating weak to no binding in these assay conditions ([Figure 3](#F3){ref-type="fig"}). Notably, the 3′ UTR WEE1 probe showed significant protein binding, with no evidence of unbound, 'free' target at concentrations used in this assay ([Figure 3](#F3){ref-type="fig"}).

![LI-RNA electrophoretic mobility shift assays used for detection and validation of new RNA-binding protein target sequences.\
NIR-labeled probes were incubated in binding buffer with recombinant FOXP3 (negative control protein), HuR or none as indicated above (Origene, MD, USA). A total of 5 μg of tRNA (Thermo Fisher Scientific, MA, USA) were used for each reaction to control for nonspecific binding. The 1× LB gels were run for 10 min at 250 V. Data are representative of at least two separate experiments.\
LB: Lithium boric acid; LI-REMSA: Lithium-based, near infrared RNA electrophoretic mobility shift assay; NIR: Near infrared; 3′UTR: 3′-Untranslated region.](btn-68-101-g3){#F3}

This work optimizes an existing method of RBP-ribonucleotide assessment by improving band resolution and decreasing total process time over traditional and more recent REMSA methods (i.e., total assay time \<1 h). Moreover, the examples here can be expanded or modified to address experimental needs based on the interactions being investigated. Others have shown the feasibility of additional end-labeled probes (i.e., alternative dyes) for assessment of competition or kinetics \[[@B5],[@B15]\]. Furthermore, when using recombinant proteins for *in vitro* determination of binding to RNA sequences, electrophoresed gels do not need to be transferred for visualization of bound complexes in our assay protocol. The modifications presented here optimize the REMSA method, particularly in process time and ease of use.
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